intermune

InterMune may receive $60 per share takeover offer

acquisition, analysis, business, esbriet, financial news, glaxosmithkline, gsk, hgsi, human genome sciences, intermune, itmn, market, merger, stock, trading

Rumors are swirling that InterMune will receive a $60 per share takeover offer. Several major drug companies are looking at InterMune following the FDA approval of its lung disease drug Esbriet. Industry sources say GlaxoSmithKlin

By FNNO Staff
fnnonline@gmail.com

Options Report: March 4th, 2011

call, cedc, colgate-palmolive, etf, eu, fda, finance, gilead sciences, ibm, intermune, jpmorgan chase, news, nuance communications, options, puts, report, s&p, southwest airlines, tivo, yrc worldwide

Welcome to the Financial News Network Options Report. On the call side, Nuance Communications is seeing 11.5 times the normal amount of calls today news that the company is forming a partnership with IBM. Southwest Airlines shares

By Stephanie Shyu
sshyu@fnno.com

InterMune Misses Q4 EPS Estimates, Guidance Awaits FDA

Published on Wed, 02/16/2011 - 17:00
By FNNO Staff in General Interest, analysis, business, earnings, eps, financial, intermune, itmn, market, news, stock, trading, Earnings Reports

InterMune currently expects to provide full-year 2011 guidance after the company meets with the FDA in March 2011 and finalizes the details of its U.S.

analysis, business, earnings, eps, financial, intermune, itmn, market, news, stock, trading

InterMune (NASDAQ:ITMN) reported Q4 EPS of 56 cents, ex-items, missing consensus estimates of 64 cents. Sales totaled $242 million.

By FNNO Staff
fnnonline@gmail.com

InterMune Soaring 90% in Early Pre-Market on European Commit

agency, chmp, commission, committee, disease, drug, ema, esbriet, eu, european, fibrosis, human, idiopathic, intermune, ipf, itmn, lung, markets, medicinal, medicines, mild, products, pulmonary, treatment, use

InterMune (ITMN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Esbriet (pi

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Shares of Apple Have Risen Above Previou...

Apple (NASDAQ:AAPL) traded at a new 52-week high today of $120.00. Approximately 55.9 ...

Next Support Level for Agilent Technolog...

Shares of Agilent Technologies (NYSE:A) opened today below their pivot of $38.21 and ha ...

Volume Spike Detected in Shares of Apple...

Shares of Apple are trading up 7.1% to $116.91 today on above average volume. About 10 ...

Next Resistance Level for Alcoa (AA) is ...

Shares of Alcoa (NYSE:AA) opened today above their pivot of $15.90 and have already rea ...

Bearish Moving Average Cross by Agilent ...

Agilent Technologies (NYSE:A) crossed under its 10-day moving average of $38.61 on a vo ...

Stock Investors Sell Off Shares of Apple...

Apple (NASDAQ:AAPL) is one of today's biggest movers, down 2.5% to $110.31. The S&P is ...

Buyers Accumulate Shares of Alcoa, Up 1....

Alcoa (NYSE:AA) is one of today's biggest movers, up 1.6% to $16.02. The Dow is down 0 ...

Shares of PRG-Schultz International Unde...

PRG-Schultz International (NASDAQ:PRGX) is one of today's biggest movers, down 1.7% to ...

Most Popular Video News